Opko Health OPK Diagnostics — Intangible Amortization
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Opko Health in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.
The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opko Health's diagnostics — intangible amortization.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opko Health's diagnostics — intangible amortization?
- Opko Health (OPK) reported diagnostics — intangible amortization of $2.53M in Q1 2026.
- How has Opko Health's diagnostics — intangible amortization changed year-over-year?
- Opko Health's diagnostics — intangible amortization decreased by 32.5% year-over-year, from $3.75M to $2.53M.
- What is the long-term trend for Opko Health's diagnostics — intangible amortization?
- Over 3 years (2022 to 2025), Opko Health's diagnostics — intangible amortization has grown at a -19.8% compound annual growth rate (CAGR), from $23.87M to $12.3M.
- What does diagnostics — intangible amortization mean?
- Represents the systematic allocation of the cost of intangible assets, such as acquired customer lists, patents, or proprietary technology, over their useful lives within the diagnostics segment. This non-cash expense reflects the consumption of acquired intellectual property. It is a key factor in reconciling the difference between operating income and cash flow.